After long haul, cancer bill passes

A bipartisan cancer research bill—aimed at tackling the disease's most dangerous forms—has finally passed Congress after nearly six years of work. The Recalcitrant Cancer Research Act passed both chambers last week as part of the conference report on defense authorization bill. The bill will create scientific frameworks for addressing the most dangerous cancers.